News and Commentary | Published:

Intercellular cannibalism fuels tumor growth

Cell Death and Differentiation volume 24, pages 759760 (2017) | Download Citation

Macroautophagy (hereafter autophagy) is a major catabolic process in eukaryotic cells, which controls quality and quantity of intracellular components, including proteins and organelles.1 An essential step during autophagy is the formation of autophagosomes, which deliver cargo such as mis-folded proteins and damaged organelles to lysosomes for degradation (Figure 1). After degradation, amino acids and building blocks of organelles are recycled into the cytoplasm for biosynthetic pathways (Figure 1). Under normal conditions, basal autophagy ensures homeostasis of the cell, but under stress conditions such as starvation, autophagy is strongly induced and promotes the survival of the cell. However, autophagy can also trigger cell death (autophagic cell death), particularly in insects.2, 3

Figure 1
Figure 1

Non-autonomous autophagy (NAA) fuels tumor growth. RasV12 scrib tumor cells (left) generate an unknown signal, which triggers NAA in neighboring wild-type cells (right). Released amino acids such as Alanine (Ala), but likely also others, are transported into RasV12 scrib tumor cells where they may be used as alternative carbon source for proliferation and invasion, triggering tumor growth

Genetic screens in yeast have uncovered more than 30 autophagy-related (Atg) genes that are involved in all steps of the autophagic process.4 Most Atg genes are conserved between yeast and mammals, and have very similar functions for autophagy in these organisms. For example, Atg8 and its mammalian homolog LC3 encode ubiquitin-like proteins that are conjugated with lipids in the membranes of the autophagosomes, and its punctate appearance in cells can be used as a marker for autophagosome formation.4 Atg7 is an essential protein for lipidation of Atg8/LC3 and its genetic inactivation is often used to block autophagy.1

Because of its essential biological role, it is not surprising that autophagy is also involved in many pathological conditions, including cancer.1, 2 Although mutations in core Atg genes are rarely found in human cancer,5 autophagy nevertheless influences the outcome of oncogenesis. However, its exact function in cancer is unclear as both tumor-suppressing as well as tumor-promoting activities of autophagy have been reported.1 For example, in epithelial tumor models in the fruit fly Drosophila melanogaster, autophagy is required for tumor growth associated with oncogenic mutations of Ras (RasV12), but it restricts growth of Notch-driven tumors.6 Not only does the oncogene appear to determine the function of autophagy for tumorigenesis, but also the cell type. Activation of autophagy has opposite effects on epithelial vs glia overgrowth induced by expression of YAP/Yorkie, the transcription factor of the Hippo growth control pathway. Epithelial YAP/Yorkie-induced overgrowth can be suppressed by autophagy, while glial overgrowth induced by the same signal is further enhanced by autophagy.6

In genetically engineered mouse models (GEMM), best characterized is the role of autophagy in tumors associated with oncogenic mutations of Kras.1 Growth of KrasG12D -induced non-small-cell lung cancer (NSCLC) and pancreas cancer depend on functional autophagy.1 If autophagy is blocked by genetic inactivation of Atg7 or Atg5, tumors do not develop beyond an initial benign state, which lead to the proposal that autophagy has tumor-suppressing activities for tumor initiation, but is required for efficient and malignant growth during tumor progression of these cancers.1 In Kras-driven gliobastoma, autophagy appears to be required for every step in tumor development.1 Similarly, autophagy promotes BrafV600E-driven melanoma. Therefore, it has been proposed that the 'autophagy-addiction' of these tumor types can be exploited for cancer therapy by therapeutic targeting of autophagy.1

In all these examples, autophagy has been experimentally manipulated inside the tumor cells and based on the obtained data, it is generally assumed that autophagy acts autonomously in tumor cells. However, a recent study in Nature, performed in Drosophila, suggested that tumor cells can also trigger non-autonomous autophagy (NAA) in neighboring normal (non-tumor) cells (Figure 1).7 In fact, the authors demonstrate that NAA has a much more profound role for tumor growth than autonomous autophagy, although the latter also contributes to final tumor volume.6, 7 The authors employed an established epithelial tumor model in Drosophila, in which tumor cells express oncogenic RasV12 and at the same time have also lost apical/basal polarity due to genetic inactivation of the gene scribble (referred to as RasV12 scrib) (Figure 1).8, 9 Epithelial RasV12 scrib cells fail to respond to stop signals for growth, fail to differentiate and grow into very aggressive, neoplastic tumors. They also invade other tissues, which eventually results in the death of the affected animal. Thus, this model mimics tumor development in human patients and provides valuable information for understanding tumorigenesis.

The authors examined the role of autophagy in the RasV12 scrib model, and using an Atg8/LC3 autophagy reporter, they surprisingly observed that autophagy is strongly induced in neighboring non-tumor cells, indicating NAA.7 To evaluate the significance of autophagy in the RasV12 scrib model, they performed a number of elegant genetic experiments, in which they specifically eliminated autophagy either in the tumor cells or in the non-tumor environment or both. While they do observe a weak requirement of autophagy tumor-autonomously, a much stronger suppression of tumor growth was observed when autophagy was inactivated in the microenvironment, even when still intact in the tumor itself.7 The authors took these experiments a step further and performed allograft transplantation experiments of RasV12 scrib tissue into autophagy-competent or autophagy-deficient hosts. The results were clear. Only when the recipient was autophagy-competent, did the transplanted RasV12 scrib tissue induce tumor growth, even when the tumor itself was autophagy-deficient.7 These results strongly suggest that NAA is very critical for efficient growth of RasV12 scrib tumors.

These observations raised two important questions. First, what are the signals from tumor cells triggering NAA and second what is the function of NAA for growth of RasV12 scrib tumors? The authors indeed found that TNF and IL-6 cytokines are involved in NAA, but this seems to be an autocrine requirement, at least for IL-6 (Figure 1).7 The authors also observed the generation of reactive oxygen species (ROS), but a specific role of ROS for NAA was not established. To answer the second question, the authors considered that autophagy provides nutrients for biosynthetic pathways of the cell. Does that imply that tumor cells promote autophagy in neighboring normal (non-tumor) cells to obtain nutrients for their own growth? To address this question, the authors scored tumor growth under a condition in which they removed an amino acid transporter specifically from tumor cells. Indeed, under these conditions, tumor growth is strongly inhibited.7 Similar results were recently reported in another paper in Nature in a model for pancreatic ductal adenocarcinoma (PDAC).10 Here, NAA was triggered in stromal (non-tumor) pancreatic stellate cells (PSCs) by tumor cells. This results in breakdown of proteins in and release of amino acids by PSCs.10 In particular, Alanine obtained from PSCs serves as an alternative carbon source for PDAC.10 Although metabolomic profiling was not performed for RasV12 scrib, these cells may display a similar amino acid requirement (Figure 1). Combined, these two reports provide strong evidence that tumor cells manipulate the microenvironment by triggering NAA to fuel their own growth.

These studies in Nature provide a possible explanation for another puzzling observation. Prompted by the finding that Kras-induced tumors in mouse models are dependent on autophagy for efficient tumor growth, a group at Pfizer/Novartis tested a large number of Kras-driven cell lines derived from human cancer patients for a similar growth requirement of autophagy. However, very disappointingly, not a single cell line showed dependence on autophagy for growth.11 Obviously, these cell lines were cultured in the absence of a tumor-supporting microenvironment and therefore an effect of NAA was not examined. It is therefore possible that NAA plays a much more significant role for tumor development than previously anticipated. It will be important in future studies to further examine the role of NAA in the tumor microenvironment for growth of human tumors. The use of organoids may be beneficial to address this question.

References

  1. 1.

    et al. Genes Dev 2016; 30: 1913–1930.

  2. 2.

    , . Mol Cell Oncol 2015; 2: e985913.

  3. 3.

    , . Curr Topics Dev Biol 2015; 114: 67–91.

  4. 4.

    . Cell Res 2014; 24: 9–23.

  5. 5.

    et al. Autophagy 2015; 11: 1668–1687.

  6. 6.

    et al. Oncogene 2015; 34: 3369–3376.

  7. 7.

    et al. Nature 2017; 541: 417–420.

  8. 8.

    , . EMBO J 2003; 22: 5769–5779.

  9. 9.

    , . Science 2003; 302: 1227–1231.

  10. 10.

    et al. Nature 2016; 536: 479–483.

  11. 11.

    et al. Proc Natl Acad Sci USA 2016; 113: 182–187.

Download references

Author information

Author notes

    • Ernesto Pérez

    Present address: Department of Biology, Austin College, 900N. Grand Ave, Suite 61611, Sherman, TX 75090, USA.

Affiliations

  1. Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 364 Plantation Street, LRB419, Worcester 01605, MA, USA

    • Ernesto Pérez
    •  & Andreas Bergmann

Authors

  1. Search for Ernesto Pérez in:

  2. Search for Andreas Bergmann in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to Andreas Bergmann.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/cdd.2017.39

Further reading

  • Cell death pathologies: targeting death pathways and the immune system for cancer therapy

    • Francesca Pentimalli
    • , Sandro Grelli
    • , Nicola Di Daniele
    • , Gerry Melino
    •  & Ivano Amelio

    Genes & Immunity (2018)

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    • Lorenzo Galluzzi
    • , Ilio Vitale
    • , Stuart A. Aaronson
    • , John M. Abrams
    • , Dieter Adam
    • , Patrizia Agostinis
    • , Emad S. Alnemri
    • , Lucia Altucci
    • , Ivano Amelio
    • , David W. Andrews
    • , Margherita Annicchiarico-Petruzzelli
    • , Alexey V. Antonov
    • , Eli Arama
    • , Eric H. Baehrecke
    • , Nickolai A. Barlev
    • , Nicolas G. Bazan
    • , Francesca Bernassola
    • , Mathieu J. M. Bertrand
    • , Katiuscia Bianchi
    • , Mikhail V. Blagosklonny
    • , Klas Blomgren
    • , Christoph Borner
    • , Patricia Boya
    • , Catherine Brenner
    • , Michelangelo Campanella
    • , Eleonora Candi
    • , Didac Carmona-Gutierrez
    • , Francesco Cecconi
    • , Francis K.-M. Chan
    • , Navdeep S. Chandel
    • , Emily H. Cheng
    • , Jerry E. Chipuk
    • , John A. Cidlowski
    • , Aaron Ciechanover
    • , Gerald M. Cohen
    • , Marcus Conrad
    • , Juan R. Cubillos-Ruiz
    • , Peter E. Czabotar
    • , Vincenzo D’Angiolella
    • , Ted M. Dawson
    • , Valina L. Dawson
    • , Vincenzo De Laurenzi
    • , Ruggero De Maria
    • , Klaus-Michael Debatin
    • , Ralph J. DeBerardinis
    • , Mohanish Deshmukh
    • , Nicola Di Daniele
    • , Francesco Di Virgilio
    • , Vishva M. Dixit
    • , Scott J. Dixon
    • , Colin S. Duckett
    • , Brian D. Dynlacht
    • , Wafik S. El-Deiry
    • , John W. Elrod
    • , Gian Maria Fimia
    • , Simone Fulda
    • , Ana J. García-Sáez
    • , Abhishek D. Garg
    • , Carmen Garrido
    • , Evripidis Gavathiotis
    • , Pierre Golstein
    • , Eyal Gottlieb
    • , Douglas R. Green
    • , Lloyd A. Greene
    • , Hinrich Gronemeyer
    • , Atan Gross
    • , Gyorgy Hajnoczky
    • , J. Marie Hardwick
    • , Isaac S. Harris
    • , Michael O. Hengartner
    • , Claudio Hetz
    • , Hidenori Ichijo
    • , Marja Jäättelä
    • , Bertrand Joseph
    • , Philipp J. Jost
    • , Philippe P. Juin
    • , William J. Kaiser
    • , Michael Karin
    • , Thomas Kaufmann
    • , Oliver Kepp
    • , Adi Kimchi
    • , Richard N. Kitsis
    • , Daniel J. Klionsky
    • , Richard A. Knight
    • , Sharad Kumar
    • , Sam W. Lee
    • , John J. Lemasters
    • , Beth Levine
    • , Andreas Linkermann
    • , Stuart A. Lipton
    • , Richard A. Lockshin
    • , Carlos López-Otín
    • , Scott W. Lowe
    • , Tom Luedde
    • , Enrico Lugli
    • , Marion MacFarlane
    • , Frank Madeo
    • , Michal Malewicz
    • , Walter Malorni
    • , Gwenola Manic
    • , Jean-Christophe Marine
    • , Seamus J. Martin
    • , Jean-Claude Martinou
    • , Jan Paul Medema
    • , Patrick Mehlen
    • , Pascal Meier
    • , Sonia Melino
    • , Edward A. Miao
    • , Jeffery D. Molkentin
    • , Ute M. Moll
    • , Cristina Muñoz-Pinedo
    • , Shigekazu Nagata
    • , Gabriel Nuñez
    • , Andrew Oberst
    • , Moshe Oren
    • , Michael Overholtzer
    • , Michele Pagano
    • , Theocharis Panaretakis
    • , Manolis Pasparakis
    • , Josef M. Penninger
    • , David M. Pereira
    • , Shazib Pervaiz
    • , Marcus E. Peter
    • , Mauro Piacentini
    • , Paolo Pinton
    • , Jochen H.M. Prehn
    • , Hamsa Puthalakath
    • , Gabriel A. Rabinovich
    • , Markus Rehm
    • , Rosario Rizzuto
    • , Cecilia M.P. Rodrigues
    • , David C. Rubinsztein
    • , Thomas Rudel
    • , Kevin M. Ryan
    • , Emre Sayan
    • , Luca Scorrano
    • , Feng Shao
    • , Yufang Shi
    • , John Silke
    • , Hans-Uwe Simon
    • , Antonella Sistigu
    • , Brent R. Stockwell
    • , Andreas Strasser
    • , Gyorgy Szabadkai
    • , Stephen W.G. Tait
    • , Daolin Tang
    • , Nektarios Tavernarakis
    • , Andrew Thorburn
    • , Yoshihide Tsujimoto
    • , Boris Turk
    • , Tom Vanden Berghe
    • , Peter Vandenabeele
    • , Matthew G. Vander Heiden
    • , Andreas Villunger
    • , Herbert W. Virgin
    • , Karen H. Vousden
    • , Domagoj Vucic
    • , Erwin F. Wagner
    • , Henning Walczak
    • , David Wallach
    • , Ying Wang
    • , James A. Wells
    • , Will Wood
    • , Junying Yuan
    • , Zahra Zakeri
    • , Boris Zhivotovsky
    • , Laurence Zitvogel
    • , Gerry Melino
    •  & Guido Kroemer

    Cell Death & Differentiation (2018)